WASHINGTON, Sept 11 (Reuters) - Data for Oscient Pharmaceuticals Corp.'s Factive antibiotic show a higher risk of skin rashes compared with other similar drugs, U.S. regulatory staff said in documents released on Monday.
WASHINGTON, Sept 11 (Reuters) - Data for Oscient Pharmaceuticals Corp.'s Factive antibiotic show a higher risk of skin rashes compared with other similar drugs, U.S. regulatory staff said in documents released on Monday.
